v3.25.2
Nature of Business and Basis of Presentation (Details)
3 Months Ended 9 Months Ended
Dec. 27, 2024
USD ($)
Nov. 08, 2024
shares
Apr. 10, 2024
USD ($)
Jul. 31, 2025
USD ($)
$ / shares
shares
Apr. 30, 2025
shares
Jan. 31, 2025
shares
Jul. 31, 2024
USD ($)
shares
Apr. 30, 2024
shares
Jul. 31, 2025
USD ($)
$ / shares
shares
Jul. 31, 2024
USD ($)
shares
Nov. 07, 2024
shares
Oct. 31, 2024
USD ($)
shares
Jan. 31, 2024
shares
Oct. 31, 2023
shares
Nature of Business and Basis of Presentation                            
Reverse stock split, conversion ratio   0.033                        
Common stock, shares outstanding (in shares) | shares   20,375,932   29,645,294         29,645,294   611,278,662 20,375,932    
Common stock, shares authorized (in shares) | shares   1,000,000,000   1,000,000,000         1,000,000,000     1,000,000,000    
Preferred shares authorized | shares   250,000                        
Cash and cash equivalents, unrestricted       $ 174,662,000     $ 159,347,000   $ 174,662,000 $ 159,347,000   $ 148,133,000    
Investments - short-term                       109,123,000    
Net proceeds from issuance of common stock                 51,626,000 $ 71,739,000        
U.S. Treasury Securities                            
Nature of Business and Basis of Presentation                            
Investments - short-term       $ 0         $ 0     $ 109,100,000    
Common Stock                            
Nature of Business and Basis of Presentation                            
Common stock, shares outstanding (in shares) | shares       29,645,294 22,776,193 21,143,772 18,461,340 15,280,202 29,645,294 18,461,340   20,375,932 15,062,045 15,020,872
Shares sold during the period | shares       6,846,992 1,626,319 690,711 3,174,005 215,457            
Amended Open Market Sales Agreement                            
Nature of Business and Basis of Presentation                            
Aggregate offering price $ 405,000,000                          
Additional amount of offering price 200,000,000                          
Amended Open Market Sales Agreement | Common Stock                            
Nature of Business and Basis of Presentation                            
Amount remaining under the amended sales agreement $ 204,922,876.65                          
Jefferies LLC, B. Riley Securities, Inc., Barclays Capital Inc., BMO Capital Markets Corp., BofA Securities, Inc., Canacord Genuity LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Loop Capital Markets LLC | Amended Open Market Sales Agreement                            
Nature of Business and Basis of Presentation                            
Aggregate offering price     $ 300,000,000                      
Shares sold during the period | shares       6,800,000         9,200,000          
Average sale of stock price per share | $ / shares       $ 5.7         $ 5.84          
Gross proceeds from sale of common stock       $ 39,000,000         $ 53,500,000          
Net proceeds from issuance of common stock       38,100,000         51,600,000          
Sales commission       800,000         1,100,000          
Payments of fees       $ 100,000         800,000          
Groton Project                            
Nature of Business and Basis of Presentation                            
Contribution received under the Technical Improvement Plan                 $ 4,000,000